Pros | ![]() 5Y returns in the top 25% of the category. ![]() Among most bought funds within the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ||
Cons | - | - |
INDMoney rank | 4/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 7 Years | ||
Fund Size | 2961 Cr | 5728 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.62% | 1.06% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 33 | 41 | ||
Top 5 Holdings | Cipla Ltd (8.86%) Cohance Lifesciences Ltd (8.81%) Sun Pharmaceuticals Industries Ltd (8.7%) Ipca Laboratories Ltd (8.16%) Gland Pharma Ltd (4.94%) | Sun Pharmaceuticals Industries Ltd (12.66%) Dr Reddy's Laboratories Ltd (9.66%) Divi's Laboratories Ltd (9.03%) Cipla Ltd (7.85%) Aurobindo Pharma Ltd (6.34%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (98.46%) Financial Services (1.54%) | Health (94.88%) Basic Materials (3.81%) Financial Services (1.31%) | ||
Equity % | 99.58% | 96.99% | ||
Debt % | - | - | ||
P/E | 40.29 | 31.57 | ||
P/B | 5.15 | 4.13 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.37% | 1.04% | ||
3-Month Return | 11.52% | 15.28% | ||
6-Month Return | -3.06% | 3.13% | ||
1-Year Return | 13.62% | 17.92% | ||
3-Year Return | 27.26% | 30.16% | ||
5-Year Return | 24.86% | 25.48% |
Sharpe | 1.34 | 1.43 | ||
Alpha | 3.07 | 3.56 | ||
Beta | 0.85 | 0.94 | ||
Standard Deviation | 14.68 | 15.37 | ||
Information Ratio | 0.06 | 1.04 |
Description | DSP Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Chirag Dagli | Dharmesh Kakkad |